Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FINISHER – Fight INflammation to Improve outcome after aneurysmal Subarachnoid HEmorRhage
2024-512314-17-00Phase 3Completed
- Sponsor
- University of Bonn
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in subarachnoid hemorrhage (SAH) comparing Dexamethasone with Placebo (2 arms). Primary endpoint: Primary: Combined mortality and severe disability at 6 months. Started Nov 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on 2024-512314-17-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512314-17-00.